Jim Simons
FLGT icon

Jim Simons’s Fulgent Genetics FLGT Stock Holding History

Jim Simons’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,000
Closed -$286K – 3325
2026
Q1 		$286K Sell
18,000
-64,864
-78% -$1.41M ﹤0.01% 2804
2025
Q4 		$2.18M Buy
+82,864
New +$2.15M ﹤0.01% 1810
2025
Q2 		– Sell
-10,400
Closed -$176K – 3652
2025
Q1 		$176K Sell
10,400
-14,500
-58% -$247K ﹤0.01% 3103
2024
Q4 		$460K Sell
24,900
-8,100
-25% -$158K ﹤0.01% 2876
2024
Q3 		$717K Sell
33,000
-10,900
-25% -$244K ﹤0.01% 2619
2024
Q2 		$861K Sell
43,900
-1,600
-4% -$33.4K ﹤0.01% 2405
2024
Q1 		$987K Sell
45,500
-1,800
-4% -$44.7K ﹤0.01% 2493
2023
Q4 		$1.37M Sell
47,300
-17,400
-27% -$466K ﹤0.01% 2202
2023
Q3 		$1.73M Sell
64,700
-32,254
-33% -$1.1M ﹤0.01% 1949
2023
Q2 		$3.59M Buy
96,954
+14,000
+17% +$488K 0.01% 1613
2023
Q1 		$2.59M Buy
82,954
+12,554
+18% +$404K ﹤0.01% 1865
2022
Q4 		$2.1M Sell
70,400
-99,200
-58% -$3.55M ﹤0.01% 2036
2022
Q3 		$6.46M Sell
169,600
-7,900
-4% -$396K 0.01% 1292
2022
Q2 		$9.7M Buy
177,500
+74,600
+72% +$4.1M 0.01% 1133
2022
Q1 		$6.42M Buy
102,900
+96,600
+1,533% +$6.36M 0.01% 1413
2021
Q4 		$634K Buy
+6,300
New +$554K ﹤0.01% 2967
2020
Q2 		– Sell
-11,521
Closed -$124K – 3551
2020
Q1 		$124K Sell
11,521
-76,900
-87% -$1.07M ﹤0.01% 3188
2019
Q4 		$1.14M Sell
88,421
-82,059
-48% -$975K ﹤0.01% 2568
2019
Q3 		$1.77M Buy
170,480
+138,414
+432% +$1.31M ﹤0.01% 2344
2019
Q2 		$214K Buy
32,066
+5,966
+23% +$36.3K ﹤0.01% 3285
2019
Q1 		$155K Buy
+26,100
New +$120K ﹤0.01% 3242

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Diametric Capital
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jim Simons's FLGT Position: Q2 2026 in Review

Jim Simons sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 18,000 shares — an estimated $286K sold.

Jim Simons first reported a position in FLGT in Q1 2019 and held it in 21 quarters. The position peaked at $9.7M in Q2 2022. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Jim Simons reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Jim Simons sold 18,000 Fulgent Genetics shares in Q2 2026, an estimated $286K.
  • Jim Simons first reported a position in Fulgent Genetics in Q1 2019 and held it in 21 quarters.
  • Jim Simons's Fulgent Genetics position peaked at $9.7M in Q2 2022.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.